Xwell (XWEL) Income from Non-Controlling Interests (2016 - 2026)
Xwell (XWEL) posted Income from Non-Controlling Interests of $190000.0 for Q1 2026, up 691.67% sequentially from $24000.0 in Q4 2025, and up 45.04% YoY from $131000.0 in Q1 2025.
Xwell (XWEL) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends
Xwell has reported Income from Non-Controlling Interests for 11 years, with the latest figure at $190000.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests rose 45.04% year-over-year to $190000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $944000.0 (up 177.65% YoY) and the FY2025 annual result came in at $885000.0, up 143.8% from the prior year.
- Income from Non-Controlling Interests rose to $190000.0 in Q1 2026 per XWEL's latest filing, from $24000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $1.5 million in Q1 2022 and troughed at -$804000.0 in Q4 2022.
- A 5-year average of $79882.4 and a median of $45000.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests plunged 200.0% in 2024, then jumped 1040.0% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at -$804000.0 in 2022, then jumped by 105.1% to $41000.0 in 2023, then slumped by 200.0% to -$41000.0 in 2024, then soared by 158.54% to $24000.0 in 2025, then surged by 691.67% to $190000.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $190000.0, $24000.0, and $513000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 14.00 Mn |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 513,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Mar 31, 2025 | 131,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 205,000.00 |
| Mar 31, 2024 | 154,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Mar 31, 2023 | -320,000.00 |
| Dec 31, 2022 | -804,000.00 |
| Sep 30, 2022 | -500,000.00 |
| Jun 30, 2022 | -9,000.00 |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | -1.44 Mn |
| Sep 30, 2021 | 998,000.00 |
| Jun 30, 2021 | -263,000.00 |